hamine.In-vitro experiments prove that the compounds have the effects of inhibiting prostate cancer cell strains PC3 and DU145, the inhibiting effect has a concentration-time dependence relation, and the compounds can be used for being developed into the medicine for inhibiting the prostate cancer....
While still in its early stages, integrative genomic testing could be the future for personalizing therapy for patients with castration-resistant prostate cancer (CRPC), according to Tomasz M. Beer, MD, FACP. In an interview withTargeted Oncology, Beer, deputy director, Knight Cancer Institute, ...
Purpose of reviewPrecision cancer medicine, the use of genomic profiling of patient tumors at the point-of-care to inform treatment decisions, is rapidly changing treatment strategies across cancer types. Precision medicine for advanced prostate cancer may identify new treatment strategies and change cli...
Complementary and Alternative Medicine for the Treatment of Prostate Cancer Complementary and alternative medicine (CAM) is the term used to describe non-orthodox methods of treatment used in conjunction with or as an alternative to conventional medicine. Complementary and alternative therapies are applied...
The ETER701 trial demonstrates that a four-drug regimen, involving the addition of anti-angiogenesis therapy to immuno-chemotherapy, improves survival outcomes for extensive-stage small-cell lung cancer — but is more indeed better when it comes to treating this intractable disease?
Despite advances in the screening and treatment of prostate cancer, the therapy options available, particularly for later stages of the disease, remain limited, and the treatment-resistant setting represents a serious unmet medical need. Moreover, diseas
The cytotoxic compounds reported in 2020 are summarized in Table 1. Most of them exhibited weak or moderate cytotoxicity. The tested cell lines included human promyelocytic leukemia cell line (HL-60), human hepatoma carcinoma cell line (SMMC-7721), human prostate cancer cell line (DU-145), ...
Habib S. T. Bukhar, Wenyuan Li, Jiayun Li, William Speier, Corey Arnold, Kyungdoc Kim, Byeonguk Bae, Yeong Won Kim, Hong-Seok Lee, Jeonghyuk Park.Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge.Nature Medicine, 2022; DOI:10.1038/s41591-021...
Novel hypoxia- and lactate metabolism-related molecular subtyping and prognostic signature for colorectal cancer Colorectal cancer (CRC) is a serious global health burden because of its high morbidity and mortality rates. Hypoxia and massive lactate production are hallmarks of the CRC microenvironment. ...
for the prevalence of tumours and cancer in animal species or what seems to be the striking vulnerability ofHomo sapiens. The central precept of Darwinian medicine is that vulnerability to cancer, and other major diseases, arises at least in part as a consequence of the 'design' limitations, ...